Document is current
Any future updates will be listed below
-
Authors
Tracy, Philip D.
Bopp, Emily
Milner, Emily
Garrido-Castro, Ana C.
Giordano, Antonio
Mayer, Erica L.
Tolaney, Sara M. https://orcid.org/0009-0001-3020-8123
Tarantino, Paolo https://orcid.org/0000-0001-8686-0228
Schlam, Ilana https://orcid.org/0000-0003-4996-0400
- License Information
-
More Information
Article History
Accepted: 9 May 2025
First Online: 28 May 2025
Declarations
:
: Emily Bopp: nothing to disclose. Emily Milner: nothing to disclose. Erica Mayer: consulting/advisory for Lilly, Novartis, AstraZeneca. Ana C. Garrido-Castro: research funding (to Institution) from Gilead Sciences, AstraZeneca, Daiichi Sankyo, Merck & Co., Zenith Epigenetics, Bristol-Myers Squibb, Novartis, Biovica, Foundation Medicine, 4D Path, and Precede Biosciences; compensated service for consulting and service on scientific advisory boards for AstraZeneca, Daiichi Sankyo, Novartis, and Pfizer; speaker honoraria from AstraZeneca, Daiichi Sankyo, Gilead Sciences, and Roche/Genentech; travel/other support from Roche/Genentech, Gilead Sciences, AstraZeneca, Daiichi Sankyo, Merck & Co., Novartis, and Pfizer. Antonio Giordano: institutional research funding from Cardiff Oncology; has served as an advisor/consultant for Pfizer; travel grant from Pfizer. Sara M. Tolaney: institutional research funding from Genentech/Roche, Merck, Exelixis, Pfizer, Lilly, Novartis, Bristol Myers Squibb, Eisai, AstraZeneca, Gilead, NanoString Technologies, Seattle Genetics, OncoPep, Daiichi Sankyo, and Menarini/Stemline; has served as an advisor/consultant for Novartis, Pfizer (SeaGen), Merck, Eli Lilly, AstraZeneca, Genentech/Roche, Eisai, Sanofi, Bristol Myers Squibb, CytomX Therapeutics, Daiichi Sankyo, Gilead, Zymeworks, Zentalis, Blueprint Medicines, Reveal Genomics, Sumitovant Biopharma, Umoja Biopharma, Artios Pharma, Menarini/Stemline, Aadi Bio, Bayer, Incyte Corp, Jazz Pharmaceuticals, Natera, Tango Therapeutics, Systimmune, eFFECTOR, Hengrui USA, Cullinan Oncology, Circle Pharma, Arvinas, BioNTech, Johnson&Johnson/Ambrx, Launch Therapeutics, Zuellig Pharma, and Bicycle Therapeutics; and receives travel support from Eli Lilly, Sanofi, Gilead, Jazz Pharmaceuticals, Pfizer, and Arvinas. Ilana Schlam: nothing to disclose. Paolo Tarantino: consulting/advisory role for AstraZeneca, Daiichi Sankyo, Roche, Gilead, Novartis, Menarini/Steamline, BioNTech. Philip D. Tracy: nothing to disclose.
: Ilana Schlam: nothing to disclose Emily Bopp: nothing to disclose Emily Milner: nothing to disclose Erica Mayer - consulting/advisory for Lilly, Novartis, AstraZeneca Ana Garrido-Castro: Research funding (to Institution) from Gilead Sciences, AstraZeneca, Daiichi Sankyo, Merck & Co., Zenith Epigenetics, Bristol-Myers Squibb, Novartis, Biovica, Foundation Medicine, 4D Path, and Precede Biosciences; compensated service for consulting and service on scientific advisory boards for AstraZeneca, Daiichi Sankyo, Novartis, and Pfizer; speaker honoraria from AstraZeneca, Daiichi Sankyo, Gilead Sciences, and Roche/Genentech; travel/other support from Roche/Genentech, Gilead Sciences, AstraZeneca, Daiichi Sankyo, Merck & Co., Novartis, and Pfizer. Antonio Giordano: institutional research funding from Cardiff Oncology; has served as an advisor/consultant for Pfizer; travel grant from Pfizer Sara Tolaney: institutional research funding from Genentech/Roche, Merck, Exelixis, Pfizer, Lilly, Novartis, Bristol Myers Squibb, Eisai, AstraZeneca, Gilead, NanoString Technologies, Seattle Genetics, OncoPep, Daiichi Sankyo, and Menarini/Stemline; has served as an advisor/consultant for Novartis, Pfizer (SeaGen), Merck, Eli Lilly, AstraZeneca, Genentech/Roche, Eisai, Sanofi, Bristol Myers Squibb, CytomX Therapeutics, Daiichi Sankyo, Gilead, Zymeworks, Zentalis, Blueprint Medicines, Reveal Genomics, Sumitovant Biopharma, Umoja Biopharma, Artios Pharma, Menarini/Stemline, Aadi Bio, Bayer, Incyte Corp, Jazz Pharmaceuticals, Natera, Tango Therapeutics, Systimmune, eFFECTOR, Hengrui USA, Cullinan Oncology, Circle Pharma, Arvinas, BioNTech, Johnson&Johnson/Ambrx, Launch Therapeutics, Zuellig Pharma, and Bicycle Therapeutics; and receives travel support from Eli Lilly, Sanofi, Gilead, Jazz Pharmaceuticals, Pfizer, and Arvinas. Paolo Tarantino: consulting/advisory role for AstraZeneca, Daiichi Sankyo, Roche, Gilead, Novartis, Menarini/Steamline, BioNTech Philip Tracy: nothing to disclose.
